CPIG
BOUT icon

Chicago Partners Investment Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Chicago Partners Investment Group’s Portfolio BOUT Stock Details BOUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,976
Closed -$136K – 402
2018
Q3 		$136K Buy
+6,976
New +$172K 0.02% 354

Other funds holding BOUT

Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Chicago Partners Investment Group's BOUT Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2018, closing a stake of 6,976 shares — an estimated $136K sold.

Chicago Partners Investment Group first reported a position in BOUT in Q3 2018 and held it in 1 quarter. The position peaked at $136K in Q3 2018. 6 funds tracked by Wall St. Rank hold BOUT as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 6,976 CapForce IBD Breakout Opportunities ETF shares in Q4 2018, an estimated $136K.
  • Chicago Partners Investment Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2018 and held it in 1 quarter.
  • Chicago Partners Investment Group's CapForce IBD Breakout Opportunities ETF position peaked at $136K in Q3 2018.
  • 6 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.